SynthesisJAMA network open2021

Use of Second-line Immunotherapy in Control Arms of Randomized Clinical Trials in Kidney Cancer: A Systematic Review.

John Sharp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.